Mindrank Ai Ltd

This study tests an experimental oral drug called MDR-001 to help adults with overweight or obesity lose weight over 52 weeks. About 738 participants will receive either the drug or a placebo, along with lifestyle advice. The main goal is to see if the drug leads to meaningful we…

This early-stage study will give a single dose of MDR-001, a GLP-1 receptor agonist tablet, to 32 people: some with mild or moderate liver impairment and some with healthy livers. Researchers want to see how the drug moves through the body and if it is safe in people with liver i…

This study looks at how two common drugs, rifampin and itraconazole, change the levels of MDR-001 in the body. It involves 28 healthy Chinese adults who will take MDR-001 alone and then with one of the other drugs. The goal is to gather safety and drug-level data, not to treat an…